mutations and complicated kar yotype. It follows a linear evolution through the CLL clone through the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding locations from the genome, are predominantly situated in active promoters or enhancers, and modify the binding internet sites of several tr